Open App
Agreement signedPublished 10 Nov 2026

GPCRT Inc. /
Exicure, Inc.

GPCRT Inc. to purchase Exicure, Inc. program assets

Terms
Not stated
Stage
Agreement signed
Source · 10 Nov 2026
See the source
Follow Exicure, Inc.
01 / BuyerGPCRT Inc.
02 / TargetExicure, Inc.
01

What happened

Exicure, Inc. and its subsidiary GPCR Therapeutics USA Inc. agreed to sell certain assets and rights relating to the GPC-100 (burixafor) program to GPCRT Inc. The agreement covers assigned contracts, intellectual property, clinical and regulatory data, and related materials and equipment.

The purchase price is KRW 6,500,000,000. The transaction is subject to closing conditions, including required approvals and consents.

02

The source

01
Source

GPCRT Inc. to purchase Exicure, Inc. program assets

Original filingUnlock with Pro
03

Timeline

  1. Published by the source

The same firms, in other posted deals

  1. Exicure, Inc. · buyer · Exicure Inc. / GPCR Therapeutics USA Inc.Before this deal
04

Deal Web

Every firm and person on this deal, and how they connect. Open any name to see their other deals.

Deal Web · 1 firm · 0 peopleHover a name to see how it connects
This dealGPCRT Inc. / Exicure, Inc.Agreement signed · Published 10 Nov 2026
TargetExicure, Inc.
This dealGPCRT Inc. / Exicure, Inc.

Agreement signed · GPCRT Inc. / Exicure, Inc. deal (Agreement signed, published 10 Nov 2026).

Published 10 Nov 2026
Timeline
  1. Published by the source
Hover or tap a name to see how it connects, and when
Deal Web as a list
  • Exicure, Inc. (Target) target this deal. Exicure, Inc.: 2 deals on Carrywatch.